Ain-Shams University Hospitals
Cairo, Egypt
Location status: Recruiting
NCT Number: NCT06092749
Chronic neuropathic lumbar pain is among one of the most widespread complaints of patients.Many approaches have been attempted to target chronic pain, with varying efficacy and risks. Transgrade (TG) epidural injection is a new technique using a Racz- Coudé needle for epidural access at a "transgrade" angle without requiring any specialized hardware or accessories. Interlaminar (IL) epidural steroid injection (ESI) is one of the procedures that involves the delivery of injectate to the epidural space through directing a needle between the laminae of two adjacent vertebrae.
Interested in participating?
Request Info21 year and older
All sexes
Interventional
Not applicable
Cairo, Egypt
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Transgrade (TG) Epidural Steroid Injection technique
Interlaminar (IL) Epidural Steroid Injection technique
Time frame: 6 month post intervention (study period)
Number of patients who experienced successful pain relief at 3 month post-intervention, which is defined as ≥ 50% reduction of numeric rating scale (NRS-11) from pre-intervention level.
Contact information is provided by the study sponsor or research team.
Ain Shams University
Other
Effectiveness of Transgrade vs Interlaminar Epidural Steroid Injection for Chronic Unilateral Lumbar Radicular Pain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06398847
Muscular Diseases, Musculoskeletal Diseases
New York, United States
View Trial DetailsNCT07712913
Diabetes Complications, Diabetes Mellitus
Salvador, Estado de Bahia, Brazil
View Trial DetailsNCT06438471
Bone Diseases, Central Nervous System Diseases
Augusta, Georgia, United States
View Trial DetailsNCT06216717
Nervous System Diseases, Neuralgia
Nice, Alpes Maritimes, France
View Trial Details